Biotechnology News

February 15, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SAFEBRIDGE® CONSULTANTS, INC. ("SafeBridge"), headquartered in Mountain View, California, has announced that Excella GmbH ("Excella") in Feucht, Germany, has met the criteria established under the...

February 15, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced favorable preclinical results for BCX5191, a novel adenine nucleoside analog targeting viral RNA polymerase for the potential treatment...

February 15, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Set to Go Global With n3D

February 15, 2012

TORONTO--(BUSINESS WIRE)--With high 2011 growth numbers for its patient flow solution, Medworxx responds to market drivers in the USA with a launch to more than 30,000 attendees at HIMSS 2012.

February 15, 2012

STOCKHOLM--(BUSINESS WIRE)--Nanologica's carrier materials play key part in the four-year EU project ORCHID. Led by GlaxoSmithKline (GSK), the €10 million project aims to discover and develop new medicines against tuberculosis.

February 15, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter and year ended December 31, 2011. Q4 2011 Highlights: Net revenues of $5.7 billion, compared to $4.4 billion in the fourth...

February 15, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced the pricing of an underwritten registered public offering of 7,500,000 shares of its common stock at a public...

February 14, 2012

MARCO ISLAND, Fla.--(BUSINESS WIRE)--(AGBT)--Agilent Technologies Inc. (NYSE:A) today expanded its SureSelect target-enrichment system with the HaloPlex target enrichment system for desktop sequencers. The product will be unveiled at the Advances...

February 14, 2012

MARCO ISLAND, Fla.--(BUSINESS WIRE)--(AGBT) – Agilent Technologies Inc. (NYSE:A) today expanded its target-enrichment platform with the SureSelect XT Human Methyl-Seq system for epigenetic research into DNA methylation sites. It is the first...

February 14, 2012

CARLSBAD, Calif. & SEOUL, South Korea--(BUSINESS WIRE)--Korean version of Nordson ASYMTEK website communicates technology developments and information for products, software, and application solutions for fluid dispensing, jetting, and...

February 14, 2012

IRVINE, Calif.--(BUSINESS WIRE)--The University of California, Irvine Extension announces that its spring Regulatory Affairs Program courses have been pre-approved by the Regulatory Affairs Professionals Society (RAPS).

February 14, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter has completed its planned acquisition of Synovis Life Technologies, Inc. The acquisition expands Baxter’s regenerative medicine and BioSurgery franchise.

February 14, 2012

WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Obama’s FY 2013 budget proposal released yesterday: “While BIO supports the broad goals...

February 14, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2011.

February 14, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2011. Revenues for the quarter were $5.4 million, compared to $1.9 million for the same...

February 14, 2012

WILLOW GROVE, Pa.--(BUSINESS WIRE)--NMS Labs remains committed to keeping ahead of the designer drug trend.

February 14, 2012

BANGALORE, India--(BUSINESS WIRE)--CosmosID and Avesthagen sign MOU for collaboration on therapeutically managing Tuberculosis, utilizing CosmosID's proprietary bioinformatics software solution, MetaSeq Genomics.

February 14, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) - the global CRO delivering excellence in clinical research - is named to the 2012 Training Top 125 list of businesses excelling in employee development.

February 14, 2012

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that it has signed a major multi-company acquisition agreement that will boost...

February 14, 2012

HORSHAM, England--(BUSINESS WIRE)--Cmed Clinical Services Appoints New Vice President of Global Medical and Regulatory Affairs

February 14, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles and Dayarn Pharma sign agreement to provide commercial services in Middle East North Africa

February 14, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced the closing of its previously announced underwritten public offering of 23,000,000 shares of its common stock at a public offering price of $2.60 per share,...

February 14, 2012

ANN ARBOR, Mich. & ROCKVILLE, Md.--(BUSINESS WIRE)--AlphaCore Pharma is awarded NHLBI SMARTT funding to manufacture rhLCAT. ABL to produce rhLCAT under cGMP as the designated biologics production facility under the SMARTT program.

February 14, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the RBC Capital Markets Healthcare Conference on Tuesday, February 28, 2012, at 2:05 p.m. (ET). The live webcast of Baxter’s...

February 14, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Allergan/Spectrum Pharmaceuticals’ EOquin Will Carve Out a Niche for Itself in the Immediate Postoperative Setting According to Decision Resources Report

February 14, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, Merck's chief financial officer is scheduled to present at the Leerink Swann 2012 Global...

February 14, 2012

BOSTON--(BUSINESS WIRE)--Dana-Farber’s Belfer Institute for Applied Cancer Science Appoints New Head of Research

February 14, 2012

WESTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Stromedix, Inc. today announced that they have entered into a definitive agreement under which Biogen Idec will acquire Stromedix Inc., a privately held biotechnology...

February 14, 2012

IRVINE, Calif.--(BUSINESS WIRE)--InnovoCommerce LLC, the world's leading clinical and investigator portal solution provider, is pleased to announce the First Annual innovoPOINT User Group Meeting in Munich, Germany.

February 14, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus announced agreements with Geisinger Health System and the University of California, San Francisco to develop clinically relevant workflows to support the use of DNA sequencing in medicine.

February 14, 2012

THUNDER BAY, Ontario--(BUSINESS WIRE)--Mitomics, focused on the research and development of mitochondrial genome-based products, announced a non-exclusive agreement with LabMD, a clinical pathology laboratory, to market PCMT in the U.S.

February 14, 2012

FLEMINGTON, N.J.--(BUSINESS WIRE)--Arno Therapeutics, Inc. (OTCBB: ARNI) announced today that it has signed an exclusive, worldwide licensing agreement with privately held Invivis Pharmaceuticals to develop the investigational drug, onapristone,...

February 14, 2012

TORONTO--(BUSINESS WIRE)--SQI and Integrated Sciences enter into an agreement to distribute multiplexed automated microarray immunoassays in Australia; the first product is a 4 plex celiac, automated test and system

February 14, 2012

TORONTO--(BUSINESS WIRE)--Allergan and Mentor Group continue to compete head to head in Europe, using a variety of tactics to gain share in various national markets.

February 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will host a live webcast of its quarterly conference call at 8:30 a.m. (ET) on Tuesday, February 28, 2012. Harvey J. Berger, M.D., chairman and...

February 14, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics Announces Positive Clinical Results for its Proprietary Weight Loss Agent, LPT3-04

February 14, 2012

BOSTON--(BUSINESS WIRE)--Lux Research announced the launch of a new China BioPharma service, extending coverage to a strategic market that poses partnering opportunities & competitive threats to western biopharma companies.

February 14, 2012

PLANEGG, Germany--(BUSINESS WIRE)--Biomax launches the PEDANT Cloud Service, offering the Pedant-Pro Sequence Analysis Suite as a subscription service that allows researchers to simply upload sequences and receive a complete analysis.

February 14, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that it will be presenting at the upcoming...

February 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today reported consolidated 2011 financial results and reviewed key progress achieved with its tivozanib and ficlatuzumab development programs in the fourth quarter of...

February 14, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences Awarded 7th Patent, 1st in Europe.

February 14, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced that it has increased its revolving line of credit with Comerica Bank from $25 million to $35 million and extended the maturity from July 11, 2013 to February 13, 2015. In...

February 14, 2012

RESTON, Va.--(BUSINESS WIRE)--Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today the launch of AptivAdvantageTM – a unique...

February 14, 2012

LONDON--(BUSINESS WIRE)--IntertechPira and EuropaBio now invite papers to be submitted for EFIB 2012. This year’s European Forum for Industrial Biotechnology and the Biobased Economy is 16-18 October in Dusseldorf, Germany.

February 14, 2012

LAUSANNE, Switzerland--(BUSINESS WIRE)--Data published in the IOVS journal shows that Gene Signal's aganirsen demonstrates activity in models of eye diseases such as AMD

February 14, 2012

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Karo Bio AB (publ) has decided to discontinue the development program for eprotirome after an animal study has demonstrated unwanted effects following long-term exposure. The planned spin-off of...